Cargando…

Clinical Care Team’s Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder caused by antigen-specific T cells and antiplatelet autoantibodies that inhibit platelet production in the bone marrow or destroy platelets in the spleen. ITP is a form of autoimmunity and is closely associated with inflammation. Corti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamed, Eman Mostafa, Meabed, Mohamed Hussein, Ibrahim, Ahmed R. N., Khalaf, Ahmed M., El Demerdash, Doaa Mohamed, Elgendy, Marwa O., Saeed, Haitham, Mahmoud, Tamer M., Salem, Heba F., Rabea, Hoda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536306/ https://www.ncbi.nlm.nih.gov/pubmed/37763764 http://dx.doi.org/10.3390/medicina59091645

Ejemplares similares

Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients
por: Hamed, Eman Mostafa, et al.
Publicado: (2023)

The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity
por: Hamed, Eman Mostafa, et al.
Publicado: (2023)

Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020)

Treatment of immune thrombocytopenic purpura: focus on eltrombopag
por: Rice, Lawrence
Publicado: (2009)

Eltrombopag Dose Adjustment During Infection-Induced Thrombocytosis in a Patient With Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2021)

A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma
por: Yasin, Ahmed K, et al.
Publicado: (2023)

Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
por: Ahmed, Mohanad A., et al.
Publicado: (2020)

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019)

Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
por: Uğur, Mehmet Can, et al.
Publicado: (2021)

Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura
por: Oo, Zayar, et al.
Publicado: (2022)

Eltrombopag for Adults and Children with Immune-Refractory Thrombocytopenic Purpura: A Systematic Review
por: de Barros Torelli, Danielle Francisco Honorato, et al.
Publicado: (2023)

Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura
por: Sert, Sena, et al.
Publicado: (2017)

Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations
por: Cook, Lucy, et al.
Publicado: (2010)

Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report
por: Zhang, Naidan, et al.
Publicado: (2022)

Chronic Myeloid Leukemia in a Patient with Previous Idiopathic Thrombocytopenic Purpura: How to Manage Imatinib Together with Eltrombopag
por: Autore, Francesco, et al.
Publicado: (2021)

The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report
por: Shaban, Mohamed, et al.
Publicado: (2022)

Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura
por: Hagihara, Masao, et al.
Publicado: (2016)

Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review
por: Shibata, Satoshi, et al.
Publicado: (2022)

Genetic clues to COVID-19 severity: exploring the stromal cell-derived factor-1/CXCL12 rs2839693 polymorphism in adult Egyptians
por: Korayem, Osama H., et al.
Publicado: (2023)

Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
por: Chang, Hong, et al.
Publicado: (2023)

Tumescent Local Infiltration Anesthesia for Mini Abdominoplasty with Liposuction
por: Mohamed, Ahmed Abdalla, et al.
Publicado: (2018)

Galangal–Cinnamon Spice Mixture Blocks the Coronavirus Infection Pathway through Inhibition of SARS-CoV-2 M(Pro), Three HCoV-229E Targets; Quantum-Chemical Calculations Support In Vitro Evaluation
por: El-Hosari, Doaa G., et al.
Publicado: (2023)

Cell Death Markers in Children with Immune Thrombocytopenic Purpura: A Preliminary Study
por: Yahia, Sohier, et al.
Publicado: (2023)

Treatment-Free Remission in Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2020)

Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
por: Elbedewy, Tamer A, et al.
Publicado: (2020)

A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
por: Allen, Rachel, et al.
Publicado: (2012)

Eltrombopag in Good's Syndrome
por: Kristiansen, Håvard Anton, et al.
Publicado: (2014)

Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis
por: Ahmed, Hafiz Abdul Waqas, et al.
Publicado: (2021)

Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
por: Abdelmahmuod, Elabbass A., et al.
Publicado: (2021)

Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial
por: Ji, Jiang, et al.
Publicado: (2023)

Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis
por: Elgendy, Sherein G., et al.
Publicado: (2021)

PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
por: Chang, H., et al.
Publicado: (2022)

Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
por: Danish, Fazal A., et al.
Publicado: (2010)

Worry from contracting COVID-19 infection and its stigma among Egyptian health care providers
por: Osman, Doaa Mohamed, et al.
Publicado: (2022)

Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases
por: Omri, Halima El, et al.
Publicado: (2015)

Screening for Latent Tuberculosis among Healthcare Workers in an Egyptian Hospital Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test
por: Anwar, Manal Mohamed, et al.
Publicado: (2019)

Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
por: Zhang, Zhuxin, et al.
Publicado: (2023)

The Eltrombopag antitumor effect on hepatocellular carcinoma
por: KUROKAWA, TOMOHIRO, et al.
Publicado: (2015)

Multiple thrombosis during eltrombopag therapy
por: Shimazu, Yutaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b1hev5rnor5ogg2ilclohifuvu